[Congressional Record Volume 166, Number 114 (Monday, June 22, 2020)]
[Daily Digest]
[Page D514]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

Committee Meetings
REPURPOSING THERAPEUTIC DRUGS FOR COVID-19: RESEARCH CHALLENGES AND 
OPPORTUNITIES
Committee on Science, Space, and Technology: On June 19, 2020, 
Subcommittee on Investigations and Oversight held a hearing entitled 
``Repurposing Therapeutic Drugs for COVID-19: Research Challenges and 
Opportunities''. Testimony was heard from Rick L. Stevens, Associate 
Laboratory Director for Computing, Environment and Life Sciences, 
Argonne National Laboratory; and public witnesses.
MISCELLANEOUS MEASURE
Committee on Armed Services: Subcommittee on Intelligence and Emerging 
Threats and Capabilities held a markup on H.R. 6395, the ``National 
Defense Authorization Act for Fiscal Year 2021''. H.R. 6395 was 
forwarded to the full Committee, without amendment.
MISCELLANEOUS MEASURE
Committee on Armed Services: Subcommittee on Strategic Forces held a 
markup on H.R. 6395, the ``National Defense Authorization Act for 
Fiscal Year 2021''. H.R. 6395 was forwarded to the full Committee, 
without amendment.
INEQUITIES EXPOSED: HOW COVID-19 WIDENED RACIAL INEQUITIES IN 
EDUCATION, HEALTH, AND THE WORKFORCE
Committee on Education and Labor: Full Committee held a hearing 
entitled ``Inequities Exposed: How COVID-19 Widened Racial Inequities 
in Education, Health, and the Workforce''. Testimony was heard from 
public witnesses.

Joint Meetings
  No joint committee meetings were held.